Pulse Biosciences (PLSE) Current Leases (2019 - 2025)

Pulse Biosciences' Current Leases history runs 7 years deep, the most recent figure standing at $1.6 million for Q4 2025.

• On a quarterly basis, Current Leases rose 15.87% year-over-year to $1.6 million in Q4 2025; TTM through Dec 2025 was $1.6 million, a 15.87% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, up 15.87% from the prior year.
• Current Leases improved to $1.6 million in Q4 2025 per PLSE's latest filing, from $1.5 million in the prior quarter.
• Across five years, Current Leases topped out at $1.6 million in Q4 2025 and bottomed at $629000.0 in Q1 2021.
• The 5-year median for Current Leases is $1.0 million (2021), against an average of $1.1 million.
• Across the five-year window, Current Leases soared 541.84% in 2021 and declined 15.31% in 2022, its largest moves.
• Year by year, Current Leases stood at $1.1 million in 2021, then retreated by 15.31% to $896000.0 in 2022, then advanced by 18.08% to $1.1 million in 2023, then grew by 28.07% to $1.4 million in 2024, then rose by 15.87% to $1.6 million in 2025.
• Per Business Quant, the three latest PLSE Current Leases figures stand at $1.6 million (Q4 2025), $1.5 million (Q3 2025), and $1.5 million (Q2 2025).